Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study

Autor: Jin-Chia Wu, Szu-Chin Li, Jian-Han Chen, Chung-Lin Hung, Cheng-Hung Lee
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Economics
medicine.medical_treatment
Cancer Treatment
Social Sciences
lcsh:Medicine
Gastroenterology
Metastasis
0302 clinical medicine
Postoperative Complications
Surgical oncology
Basic Cancer Research
Medicine and Health Sciences
lcsh:Science
Multidisciplinary
Liver Neoplasms
Middle Aged
Surgical Oncology
Oncology
030220 oncology & carcinogenesis
030211 gastroenterology & hepatology
Female
Diagnosis code
Cohort study
Research Article
Hepatic Resection
Clinical Oncology
medicine.medical_specialty
Surgical and Invasive Medical Procedures
03 medical and health sciences
Digestive System Procedures
Health Economics
Stomach Neoplasms
Gastrectomy
Statistical significance
Internal medicine
Gastrointestinal Tumors
medicine
Hepatectomy
Humans
Survival analysis
Aged
Surgical Resection
business.industry
lcsh:R
Cancer
Cancers and Neoplasms
medicine.disease
Survival Analysis
Health Care
Gastric Cancer
lcsh:Q
Clinical Medicine
business
Health Insurance
Zdroj: PLoS ONE, Vol 12, Iss 7, p e0182255 (2017)
PLoS ONE
ISSN: 1932-6203
Popis: Introduction Hepatic metastases are diagnosed synchronously in 3–14% of patients with gastric cancer, and metachronously in up to 37% of patients following ‘‘curative” gastrectomy. Most patients who have gastric cancer and hepatic metastasis are traditionally treated with palliative chemotherapy. The impact of liver resection is still controversial. We attempted to assess whether liver resection can improve survival in cases of metachronous hepatic metastases from gastric cancer through a nationwide database. Materials and methods We conducted a nationwide cohort study using a claims dataset from Taiwan’s National Health Insurance Research Database (NHIRD). We identified all patients with gastric cancer (diagnostic code ICD-9: 151.x) from the Registry for Catastrophic Illness Patient Database (RCIPD) of the NHIRD who received gastrectomy and as well as those with metachronous (≥180 days after gastrectomy) liver metastases (ICD-9 code: 197.7) between 1996/01/01 and 2012/12/31. Patients with other malignancies, with metastasis in the initial admission for gastrectomy and with other metastases were excluded. They were divided into two groups, liver resection group and non-resection group. All patients were followed till 2013/12/31 or withdrawn from the database because of death. Results 653 patients who fullfilled the inclusion criteria were included in the research. They were divided into liver resection group (34 patients) and non-resection group (619 patients). There were no differences between the two groups in gender, Charlson Comorbidity index and major coexisting disease. Kaplan-Meier analysis demostrated the liver resection group had significantly better overall survival than the non-resection group. (1YOS: 73.5% vs. 19.7%, 3YOS: 36.9% vs. 6.6%, 5YOS: 24.5.3% vs. 4.4%, p
Databáze: OpenAIRE